Real-world Evidence for the Safety of Oral JAK Inhibitors in Inflammatory Skin Diseases: A Systematic Review and Meta-analysis

Published: 17 March 2025| Version 1 | DOI: 10.17632/j22ywmt8sj.1
Contributor:
Hui Liu

Description

Attachment 1_PRISMA 2020 checklist; Attachment 2_Search strategy; Attachment 3_List of excluded records and reason of exclusion; Attachment 4_Assessment results of risk of bias; Attachment 5_Result of Meta-analysis using the "PFT" method; Attachment 6_Result of Meta-analysis using the "PRAW" method;

Files

Categories

Dermatology

Funders

  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
    Grant ID: Research Unit of Evidence⁃based Evaluation and Guidelines (2021RU017)

Licence